Gilead Sciences Inc.

NASDAQ: GILD · Real-Time Price · USD
118.35
-0.67 (-0.56%)
At close: Aug 15, 2025, 3:59 PM
119.00
0.55%
After-hours: Aug 15, 2025, 07:49 PM EDT

Gilead Sciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
28.86B 28.73B 28.75B 28.3B 27.8B 27.45B 27.11B 27.39B 27.38B 27.04B 27.28B 27.14B 27.52B 27.47B 27.3B 27.48B 26.64B 25.56B
Cost of Revenue
6.2B 6.24B 6.25B 6.76B 6.75B 6.65B 6.5B 5.8B 5.63B 5.63B 5.66B 6.89B 6.72B 6.66B 6.6B 5.37B 5.29B 4.96B
Gross Profit
22.67B 22.5B 22.5B 21.54B 21.05B 20.8B 20.62B 21.59B 21.75B 21.41B 21.62B 20.25B 20.8B 20.81B 20.7B 22.11B 21.35B 20.6B
Operating Income
8.05B 8.22B 1.66B 822M 2.56B 1.58B 7.61B 8.26B 8.47B 8.84B 7.33B 6B 7.01B 7.22B 9.92B 11.63B 9.79B 4.56B
Interest Income
304M 266M 280M 195M 249M 214M 106M 106M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
7.2B 6.83B 690M 176M 1.54B 1.07B 6.86B 7.24B 7.35B 7.27B 5.81B 4.54B 5.55B 5.86B 8.28B 9.33B 6.72B 1.93B
Net Income
6.31B 5.96B 480M 126M 1.05B 484M 5.66B 5.88B 5.48B 5.58B 4.59B 3.33B 4.14B 4.51B 6.22B 7.39B 5.16B 301M
Selling & General & Admin
5.92B 5.93B 6.05B 5.76B 5.65B 6.12B 6.06B 6.5B 6.4B 5.91B 5.67B 5.3B 5.28B 5.27B 5.25B 5.33B 5.24B 5.13B
Research & Development
5.91B 5.77B 5.91B 5.67B 5.74B 5.79B 5.72B 3.16B 2.85B 2.55B 4.98B 8.16B 8.11B 8.1B 5.28B 4.83B 4.88B 5.09B
Other Expenses
2.79B 2.58B 8.89B 9.28B 7.11B 7.31B 1.23B 3.66B 4.02B 4.12B 3.64B 786M 403M 211M 265M 329M 1.44B 5.82B
Operating Expenses
14.62B 14.27B 20.84B 20.72B 18.5B 19.22B 13.01B 13.33B 13.27B 12.57B 14.29B 14.24B 13.79B 13.58B 10.79B 10.48B 11.56B 16.04B
Interest Expense
1B 984M 978M 981M 975M 968M 944M 918M 915M 927M 935M 947M 968M 982M 1B 1.03B 1.02B 1B
Selling & Marketing Expenses
3.52B 3.46B 3.45B 3.41B 2.37B 1.57B 826M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
20.81B 20.51B 27.09B 27.48B 25.25B 25.87B 19.51B 19.13B 18.91B 18.2B 19.95B 21.13B 20.51B 20.25B 17.39B 15.85B 16.85B 21B
Income Tax Expense
890M 860M 211M 63M 506M 617M 1.25B 1.41B 1.91B 1.73B 1.25B 1.23B 1.44B 1.37B 2.08B 1.96B 1.58B 1.66B
Shares Outstanding (Basic)
1.25B 1.25B 1.25B 1.25B 1.25B 1.25B 1.25B 1.25B 1.25B 1.25B 1.25B 1.25B 1.26B 1.25B 1.26B 1.26B 1.25B 1.26B
Shares Outstanding (Diluted)
1.25B 1.26B 1.26B 1.25B 1.25B 1.25B 1.26B 1.26B 1.26B 1.26B 1.26B 1.26B 1.26B 1.26B 1.26B 1.26B 1.26B 1.26B
EPS (Basic)
5.06 4.78 0.38 0.10 0.85 0.40 4.55 4.71 4.39 4.46 3.66 2.65 3.28 3.58 4.95 5.89 4.12 0.25
EPS (Diluted)
5.02 4.75 0.37 0.09 0.82 0.36 4.50 4.66 4.35 4.43 3.64 2.64 3.27 3.57 4.93 5.86 4.10 0.23
EBITDA
10.97B 10.58B 4.43B 3.92B 5.27B 4.78B 10.5B 10.69B 10.64B 10.41B 8.85B 7.6B 8.62B 8.95B 11.33B 12.3B 9.51B 4.53B
EBIT
8.2B 7.81B 1.67B 1.16B 2.51B 2.04B 7.8B 8.15B 8.27B 8.19B 6.75B 5.49B 6.52B 6.84B 9.28B 10.36B 7.74B 2.93B
Depreciation & Amortization
2.77B 2.77B 2.77B 2.76B 2.76B 2.74B 2.69B 2.53B 2.37B 2.22B 2.1B 2.11B 2.11B 2.1B 2.05B 1.94B 1.77B 1.6B